menu
    • menu
    [{"orgOrder":0,"company":"Tagworks Pharmaceuticals","sponsor":"Ysios Capital","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"NETHERLANDS","productType":"Other Large Molecule","year":"2023","type":"Series A Financing","leadProduct":"TGW101","moa":"Undisclosed","graph1":"Oncology","graph2":"IND Enabling","graph3":"Tagworks Pharmaceuticals","amount2":0,"highestDevelopmentShortName":"IND","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Tagworks Pharmaceuticals \/ Ysios Capital","highestDevelopmentStatusID":"5","companyTruncated":"Tagworks Pharmaceuticals \/ Ysios Capital"},{"orgOrder":0,"company":"Tagworks Pharmaceuticals","sponsor":"Ysios Capital","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"NETHERLANDS","productType":"Other Large Molecule","year":"2023","type":"Series A Financing","leadProduct":"TGW101","moa":"Undisclosed","graph1":"Oncology","graph2":"IND Enabling","graph3":"Tagworks Pharmaceuticals","amount2":0,"highestDevelopmentShortName":"IND","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Tagworks Pharmaceuticals \/ Ysios Capital","highestDevelopmentStatusID":"5","companyTruncated":"Tagworks Pharmaceuticals \/ Ysios Capital"},{"orgOrder":0,"company":"Tagworks Pharmaceuticals","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"NETHERLANDS","productType":"Antibody-drug Conjugate","year":"2025","type":"Inapplicable","leadProduct":"TGW101","moa":"TAG-72","graph1":"Oncology","graph2":"IND Enabling","graph3":"Tagworks Pharmaceuticals","amount2":0,"highestDevelopmentShortName":"IND","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Intravenous Infusion","sponsorNew":"Tagworks Pharmaceuticals \/ Inapplicable","highestDevelopmentStatusID":"5","companyTruncated":"Tagworks Pharmaceuticals \/ Inapplicable"}]

    Find Clinical Drug Pipeline Developments & Deals by Tagworks Pharmaceuticals

    Menu

    Tagworks Pharmaceuticals

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Tagworks Pharmaceuticals

                            Netherlands arrow
                            China Battery Fair
                            Not Confirmed

                            Tagworks Pharmaceuticals

                            Netherlands arrow
                            China Battery Fair
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : TGW101

                            Therapeutic Area : Oncology

                            Study Phase : IND Enabling

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Tagworks Starts Phase 1 Trial for TGW101, Appoints New Chief Medical Officer

                            Details : TGW101 is a next-generation, first-in-class ADC targeting TAG-72 with an MMAE payload, developed based on Tagworks proprietary Click-to-Release linker chemistry.

                            Product Name : TGW101

                            Product Type : Antibody-drug Conjugate

                            Upfront Cash : Inapplicable

                            April 22, 2025

                            Lead Product(s) : TGW101

                            Therapeutic Area : Oncology

                            Highest Development Status : IND Enabling

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Tagworks Pharmaceuticals

                            Netherlands arrow
                            China Battery Fair
                            Not Confirmed

                            Tagworks Pharmaceuticals

                            Netherlands arrow
                            China Battery Fair
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : TGW101

                            Therapeutic Area : Oncology

                            Study Phase : Preclinical

                            Sponsor : Ysios Capital

                            Deal Size : $65.0 million

                            Deal Type : Series A Financing

                            DEALS_DEV arrow-down

                            Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics

                            Details : The financing will support the advancement of TGW101, a click-cleavable ADC targeting tumor-associated glycoprotein 72, and the company’s proprietary Click-to-Release platform.

                            Product Name : TGW101

                            Product Type : Other Large Molecule

                            Upfront Cash : Undisclosed

                            June 22, 2023

                            Lead Product(s) : TGW101

                            Therapeutic Area : Oncology

                            Highest Development Status : Preclinical

                            Sponsor : Ysios Capital

                            Deal Size : $65.0 million

                            Deal Type : Series A Financing

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Tagworks Pharmaceuticals

                            Netherlands arrow
                            China Battery Fair
                            Not Confirmed

                            Tagworks Pharmaceuticals

                            Netherlands arrow
                            China Battery Fair
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : TGW101

                            Therapeutic Area : Oncology

                            Study Phase : Preclinical

                            Sponsor : Ysios Capital

                            Deal Size : $65.0 million

                            Deal Type : Series A Financing

                            DEALS_DEV arrow-down

                            Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics

                            Details : The financing will support the advancement of TGW101, Tagworks' lead click-cleavable ADC program targeting tumor-associated glycoprotein 72 (TAG72), and the company's proprietary Click-to-Release platform.

                            Product Name : TGW101

                            Product Type : Other Large Molecule

                            Upfront Cash : Undisclosed

                            June 21, 2023

                            Lead Product(s) : TGW101

                            Therapeutic Area : Oncology

                            Highest Development Status : Preclinical

                            Sponsor : Ysios Capital

                            Deal Size : $65.0 million

                            Deal Type : Series A Financing

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth